Ask AI
ProCE Banner Series

A Seat at the HS Expert’s Table: A Master Class in Diagnosis and Treatment Advances for Hidradenitis Suppurativa

This expert-led masterclass brings together leading HCPs to explore the latest advances in the diagnosis and management of hidradenitis suppurativa (HS). Through a certified on-demand webcast, expert-authored ClinicalThought commentaries, and downloadable slides, learners will gain actionable, evidence-based strategies to improve patient outcomes across the full HS disease spectrum.

This INC Program does not qualify for continuing medical education (CME) credit and is independent of the official AAD Meeting as planned by the Scientific Assembly Committee.

Who Should Attend

This activity is intended for dermatologists, dermatology residents and fellows, nurse practitioners, and physician associates and other HCPs who care for patients with hidradenitis suppurativa.

All Events

A Seat at the HS Expert’s Table: A Master Class in Diagnosis and Treatment Advances for Hidradenitis Suppurativa

Upcoming Events

March

26

2026

6:30 PM - 8:30 PM Mountain Time (MT)

In-person

Embassy Suites Denver Convention Center, 1420 Stout Street, Denver, Colorado 80202

7:00 PM - 8:30 PM Mountain Time (MT)

Virtual

Topics

Hidradenitis Suppurativa

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize the identification and management of patients with hidradenitis suppurativa.

Target Audience
This activity is intended for dermatologists, dermatology residents and fellows, nurse practitioners, and physician associates and other HCPs who care for patients with hidradenitis suppurativa.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply consensus-driven diagnostic strategies to enhance the accuracy and timeliness of HS diagnosis

  • Examine key elements of HS pathophysiology, including how they contribute to disease progression and the therapeutic rationale for targeting them with novel and emerging agents

  • Assess available and emerging targeted therapies for HS according to clinical profile, safety, and efficacy

  • Formulate comprehensive care plans that consider QoL and comorbidities for patients with HS, including those with skin of color

Accreditation

This activity is not certified for CME/CE credit.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education, in partnership with the HS Foundation

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by educational grants from Incyte Corporation, Novartis Pharmaceuticals Corporation, and UCB Inc.

Incyte Corporation

Novartis Pharmaceuticals Corporation

UCB Inc.

Partners

HS Foundation

ProCE Banner

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191